¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"trachoma bodies"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Aschoff bodies
    ¾Æ¼îÇÁ¼Òü
  • Cabot ring bodies
    Ä«º¸Æ®°í¸®¼Òü
  • Cowdry type A inclusion bodies
    Ä«¿ìµå¸®AÇüÆ÷ÇÔü, Ä«¿ìµå¸®AÇüºÀÀÔü
  • Cowdry type B inclusion bodies
    Ä«¿ìµå¸®BÇüÆ÷ÇÔü, Ä«¿ìµå¸®BÇüºÀÀÔü
  • Call-Exner bodies
    Ä®-¿¢½º³Ê¼Òü
  • Guarnieri¡¯s bodies
    °ú¸£´Ï¿¡¸®Æ÷ÇÔü, °ú¸£´Ï¿¡¸®ºÀÀÔü
  • Heinz bodies
    ÇÏÀÎÃ÷¼Òü
  • Howell-Jolly bodies
    ÇÏ¿ù-Á¹¸®¼Òü
  • Mallory bodies
    ¸È·Î¸®¼Òü
  • Negri bodies
    ³×±×¸®¼Òü
  • Russell¡¯s bodies
    ·¯¼¿¼Òü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trachoma
    Æ®¶óÄÚ¸¶
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trachoma
    Æ®¶óÄÚ¸¶
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psittacosis-lymphogranuloma-trachoma (PLT) group
    PLT±º Ŭ¶ó¹Ìµð¾Æ
  • psittacosis-lymphogranuloma-trachoma group
    ¾Þ¹«(»õ)º´ ¸²ÇÁÀ°¾ÆÁ¾Áõ Æ®¶óÄÚ¸¶±º(¡­ë¿ä´ðþñø¡­ÏØ).
  • psittacosis-lymphogranuloma-trachoma group
    ¾Þ¹«(»õ)º´(¡­Ü») ¸²ÇÁÀ°¾ÆÁ¾Áõ Æ®¶óÄÚ¸¶±º(¡­ë¿ä´ðþñø¡­ÏØ)
  • Ketone bodies
    ÄÉÅæÃ¼(¡­ô÷)
  • Negri bodies
    ³×±×¸®¼Òü ±¤°ßº´ºÀÀÔ¼Òü .
  • Nissls bodies
    ´Ï½½¼Òü.
  • amyloid bodies<³ª> corpora amylacea
    ¾Æ¹Ð·ÎÀ̵å¼Òü(¡­á³ô÷).
  • guarneri bodies
    Guarneri ¼Òü
  • quadrigeminal bodies
    »ç±¸Ã¼(ÞÌÎøô÷).
  • quadrigeminal bodies
    ȍ
  • removal of foreign bodies in root canal
    ±Ù°ü³»À̹°Á¦°Å¹ý(ÐÆÎ·Ò®ì¶Úªð¶ËÛ Ûö).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • papillary trachoma
    À¯µÎ¼º(êáÔéàõ) Æ®¶ó ÄÚ¸¶.
  • psittacosis-lymphogranuloma-trachoma (PLT) group
    PLT±º Ŭ¶ó¹Ìµð¾Æ
  • psittacosis-lymphogranuloma-trachoma group
    ¾Þ¹«(»õ)º´ ¸²ÇÁÀ°¾ÆÁ¾Áõ Æ®¶óÄÚ¸¶±º(¡­ë¿ä´ðþñø¡­ÏØ).
  • psittacosis-lymphogranuloma-trachoma group
    ¾Þ¹«(»õ)º´(¡­Ü») ¸²ÇÁÀ°¾ÆÁ¾Áõ Æ®¶óÄÚ¸¶±º(¡­ë¿ä´ðþñø¡­ÏØ)
  • trachoma
    Æ®¶óÄÚ¸¶
  • trachoma
    Æ®¶óÄÚ¸¶
  • trachoma cicatriceum ³ª
    ¹ÝÈ缺(ÚîýÝàõ) Æ®¶óÄÚ¸¶
  • trachoma deformans ³ª
    ±âÇü¼º(Ðöû¡àõ) Æ®¶óÄÚ¸¶
  • trachoma follicular
    ¿©Æ÷¼º(æ¤øààõ) Æ®¶óÄÚ¸¶
  • trachoma granulosum ³ª
    °ú¸³¼º(Ψí£àõ) Æ®¶óÄÚ¸¶
  • trachoma of vocal bands
    °áÀý(¼º) ¼º´ë¿°
  • trachoma of vocal bands
    °áÀý¼º ¼º´ë¿°(Ì¿ï½àõá¢Óáæú)
  • trachoma, papillary
    À¯µÎ¼º(êáÔéàõ) Æ®¶óÄÚ¸¶
  • war ophthalmia =trachoma
    Æ®¶óÄÚ¸¶, ÀüÀï¾È¿°(îúî³äÑæú)
  • amyloid bodies<³ª> corpora amylacea
    ¾Æ¹Ð·ÎÀ̵å¼Òü(¡­á³ô÷).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • herring bodies
    Ç층ü(ô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PLT pancreatic lymphocytic infiltration; platelet; primed lymphocyte test; primed lymphocyte typing; psi...
TRIC trachoma inclusion conjunctivitis [organism]
ASAB Anti-Sperm Anti-Bodies
HJ Howell-Jolly [bodies]
P/I/X patients, indicators, external bodies
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AB Asbestos bodies
ABs Asbestos bodies
CBs Carotid bodies
CBs Coiled bodies
DLB Dementia with Lewy Bodies
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • trachoma
    °ú¸³¼º °á¸·¿°
    °á¸·°ú °¢¸·¿¡ »ý±â´Â ¸¸¼º °¨¿°º´À¸·Î½á Áõ»óÀ¸·Î´Â ±¤¼± °øÆ÷Áõ, ÅëÁõÀÌ ³ªÅ¸³ª¸ç, ¶ÇÇÑ °è¼Ó ´«¹°À» È긮°Ô µÈ´Ù. ÇѶ§´Â ÀÌ º´ÀÌ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ¾ß±âµÈ´Ù°í »ý°¢µÇ¾úÀ¸³ª ÇöÀç´Â Ŭ¶ó¹Ìµð¾Æ Æ®¶óÄÚ¸¶Æ¼½º ±ÕÁÖ·Î ºÐ·ùµÇ´Â ¼¼±Õ¿¡ ÀÇÇØ ¹ßº´µÇ´Â Áúº´À¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
  • bodies of Arantius
    ¾Æ¶õƼ¿ì½º °áÀý
    ´ëµ¿¸ÆÆÇÀÇ °áÀý.
  • Cabot's ring bodies
    Ä«º¸Æ® ȯ»óü
    ÁßÁõ ºóÇ÷ ȯÀÚÀÇ ÀûÇ÷±¸¿¡¼­ º¼ ¼ö Àִ ȯ»ó ¶Ç´Â 8ÀÚÇüÀÇ ¼±À̸ç, Wright-Leishman ¿°»öü¿¡¼­ Àû»öÀ¸·Î, ¿°È­ ¸ÞƿŸÀÌ¿À´ÑÀÇ ¿¡¿À»êÈ­¹° ¿°»ö¿¡¼­ û»öÀ¸·Î ¿°»öµÈ´Ù.
  • Doehle bodies
    Doehle ¼Òü
  • fibrin bodies of pleura
    È丷 ¼¶À¯ ¼Òü
    È丷°­ ±âÀúºÎ±Ù¿¡ ÀÖ´Â °¡µ¿¼º ¶Ç´Â Á¡Âø¼º, ±¸»ó, µ¿Áú¼º, ±×¸®°í ÇѰ谡 ¸íÈ®ÇÑ À¯¹éü·Î¼­, È丷 »ïÃâ¾×, ±âÈä ¶Ç´Â Ç÷±âÈäÁõ¿¡¼­ ÀÌÂ÷ÀûÀ¸·Î ¹ß»ýÇÑ´Ù.
  • Herring bodies
    Ç층 ¼Òü
    Çϼöü ½Å°æºÎ¿¡ Á¸ÀçÇÏ´Â ÃÊÀÚÁú ¶Ç´Â ±³ÁúÀÇ µ¢¾î¸®.
  • inclusion bodies
    ºÀÀÔü, ºÀÀÔ ¼Òü
    ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ³»Áö ÇÙÁú ³»¿¡ ³ªÅ¸³ª´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ºÒ±ÔÄ¢ÇÑ ¼ÒüÀ̸ç, ±¤°ßº´, µÎâ, ÇãÇǽº¿Í °°Àº ¿©°ú¼º ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ °¨¿°Áõ¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • Leishman-Donovan bodies
    ·¹½´¸¸-µµ³ë¹Ýü
    Ä®¶ó-¾ÆÀÚ¸£ º´¿¡ °É¸° ȯÀÚÀÇ Æ¯È÷ ºñÀå°ú °£ÀÇ ¼¼¸Á ³»ÇÇ ¼¼Æ÷ ³»¿¡¼­ °üÂûµÇ´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ¼Òü·Î¼­, ÀÌ º´À» ÀÏÀ¸Å°´Â ±â»ýÃæÀÎ ¿ø»ýµ¿¹°ÀÇ ¹«Æí¸ð ¼¼Æ÷ ³»¿¡ ÀÖ´Ù. ¶ÇÇÑ ÇǺμº ·¹½´¸¶´Ï¾ÆÁõ¿¡¼­ ´ë½Ä ¼¼Æ÷³»¿¡¼­µµ °üÂûµÈ´Ù. L. tro
  • Mooser bodies
    ¹«¿ì¼­ ¼Òü
    ¹ßÁøÆ¼Çª½ºÀÇ ¾î¶² Çü¿¡ À־ Ãʸ· »óÇÇ ¼¼Æ÷ÀÇ »ïÃâ¾×¿¡¼­ °üÂûµÇ´Â ¸®ÄÉÄ¡¾Æ ¸ð¾çÀÇ ¼Òü.
  • Nissl bodies
    ´Ï½½ ¼Òü
    »ö¼Ò ģȭü, ŸÀ̱׷ÎÀÌµå ¹°Áú, Ç¥¹® ¹°Áú. ¿°±â¼º ¿°·á·Î ¿°»öµÇ°í, ³»ÇüÁú ¼¼¸Á°ú ¶óÀ̺¸¼ØÀ¸·Î ±¸¼ºµÈ ½Å°æ ¼¼Æ÷³»ÀÇ Ä¿´Ù¶õ °ú¸³.
  • purine bodies test
    Ǫ¸°Ã¼ ½ÃÇè
  • rice bodies
    ¹Ì¸³Ã¼
    °üÀý°ÇÀ̳ª ¼öȰ¾× ³¶Á¾¾× ¼Ó¿¡ Çü¼ºµÇ´Â ¹Ì¸³»óÀÇ ¼Òü.
  • Schaumann's bodies
    »þÀ¯¸¸Ã¼
    Àû»öÀÌ µµ´Â °¥»öÀÇ °áÀý»ó ¶Ç´Â Á¶°³ ¸ð¾çÀÇ »ç¸£ÄÚÀ̵µ½Ã½º º´º¯¿¡¼­ °üÂûÇÒ ¼ö ÀÖ´Â ¼Òü.
  • ultimobranchial bodies
    ÈÄ»õü
    Á¦ 5Àεγ¶ ȤÀº »õ³¶ÀÇ ¹èÀ¯µµÃ¼·Î¼­, ºÎ°©»ó¼±À» ¿¬ÇÏ¿© °©»ó¼±°ú À¶ÇÕÇÑ´Ù.
  • vermiform bodies
    Ãæ¾ç ¼Òü
    °£ÀÇ ÄíÆÛ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â ¼¼Æ÷¸·ÀÇ Æ¯ÀÌÇÑ µ¿ ¸ð¾çÀÇ ÇÔ¸ô·Î¼­ ÆòÇื°ú Èñ¹ÌÇÑ È¾¹® »çÀÌ¿¡ Áß¾Ó ¼±»ó ±¸Á¶¸¦ °¡Áö°í ÀÖ´Ù. ÀÌ¿Í À¯»çÇÑ ±¸Á¶¸¦ ¾î¶² Àå±â³»ÀÇ ´ë½Ä¼¼Æ÷¿Í Ç¥ÇÇÀÇ ¶û°Ô¸£Çѽº ¼¼Æ÷¿¡¼­µµ °üÂûÇÒ ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
trachoma bodies Distinctive, complex, intracytoplasmic forms found in the conjunctival epithelial cells of persons in the acute phase of trachoma, less frequently in later stages, varying from 1) discrete acidophilic granules (approximately 250 nm in diameter), to 2) irregular clumps of such material embedded in a basophilic matrix, to 3) relatively large basophilic body's (approximately 700 to 1000 nm in diameter), to 4) large basophilic body's that include discrete, tiny, acidophilic granules.
Synonym: Halberstaedter-Prowazek bodies, Prowazek-Greeff bodies.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
granular trachoma <ophthalmology> The ordinary form of trachoma marked by the presence of granulations on the conjunctiva.
Synonym: granular trachoma.
(05 Mar 2000)
trachoma <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
trachoma glands Lymph nodes in the palpebral conjunctiva.
Synonym: trachoma glands.
(05 Mar 2000)
trachoma virus Former name for Chlamydia trachomatis.
(05 Mar 2000)
follicular trachoma <ophthalmology> The ordinary form of trachoma marked by the presence of granulations on the conjunctiva.
Synonym: granular trachoma.
(05 Mar 2000)
alcoholic hyaline bodies Large, poorly defined accumulations of eosinophilic material in the cytoplasm of damaged hepatic cells in certain forms of cirrhosis and marked fatty change especially due to alcoholism.
Synonym: alcoholic hyalin, alcoholic hyaline bodies.
(05 Mar 2000)
Alder bodies Granular inclusions in polymorphonuclear leukocytes; they take on a dark colour with Giemsa-Wright stain and react metachromatically with toluidine blue.
See: Alder's anomaly.
(05 Mar 2000)
amyloid bodies of the prostate An obsolete term for small masses of colloid material often present in the tubules of the gland.
See: corpus amylaceum.
(05 Mar 2000)
aortic bodies Small clusters of chemoreceptive and supporting cells located near the aortic arch, the pulmonary arteries, and the coronary arteries. The aortic bodies sense pH, carbon dioxide, and oxygen concentrations in the blood and participate in the control of respiration.
(12 Dec 1998)
Arnold's bodies Small portions or minute fragments of erythrocytes (sometimes mistaken for blood platelets), or small "ghosts" of erythrocytes.
(05 Mar 2000)
asbestos bodies Ferruginous body's with asbestos fibres as a core; a histologic hallmark of exposure to asbestos.
(05 Mar 2000)
Aschoff bodies <pathology> Small granulomas composed of macrophages, lymphocytes and multinucleate cells grouped around eosinophilic hyaline material derived from collagen. Characteristic of the myocarditis of rheumatic fever.
(18 Nov 1997)
Auer bodies Rod-shaped structures of uncertain nature in the cytoplasm of immature myeloid cells, especially myeloblasts, in acute myelocytic leukaemia; may be an abnormal form of lysosomes; they contain peroxidase and acid phosphatase, and stain red by azure-eosin stains.
Synonym: Auer rods.
(05 Mar 2000)
Babes-Ernst bodies Intracellular granules, present in many species of bacteria, which possess a strong affinity for nuclear stains.
(05 Mar 2000)
bigeminal bodies A bilateral single swelling of the roofplate of the embryonic midbrain that later in development becomes subdivided into a superior and an inferior colliculus.
See: quadrigeminal bodies.
Synonym: corpora bigemina.
(05 Mar 2000)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
trachoma bodies inclusion bodies found in clusters in the cytoplasm of the epithelial cells from the conjunctiva of a trachomatous eye; called also Halberstaedter-Prowazek b's, Prowazek's b's, and Prowazek-Greeff b's.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trachoma
    Æ®¶óÄÚ¸¶
  • trachoma
    Æ®¶óÄÚ¸¶
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á